Monday, November 11, 2019 3:53:34 PM
I picked up some shares last year around this time as they were being thrown out for tax losses @$0.05 and under.
I think cardiac PET is better than SPECT and the company announced last year they had made some sales, which caught my attention. I called the company and asked if they were tow seperate sales, as they curiously released the same generic PR on different dates (9/6/2018 to their website and 10/2/2018 to the newswire), their President told me that had made multiple sales in the past year after not making any since 2013, that there was a watershed moment in cardiac PET happening with newer studies and the scarcity of Tc-99 for SPECT at the time.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM